stem cell therapy (Mogam/Green Cross/Samsung Medical)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestem cell therapy (Mogam/Green Cross/Samsung Medical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMogam Biotechnology Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMogam Biotechnology InstituteGreen Cross Holdings Co LtdSamsung Medical Center
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A